Adicet Bio Inc (LTS:0HX7)
$ 0.8937 0.0228 (2.65%) Market Cap: 75.50 Mil Enterprise Value: -108.37 Mil PE Ratio: 0 PB Ratio: 0.36 GF Score: 31/100

resTORbio, Inc. - Special Call Transcript

Feb 07, 2019 / 01:30PM GMT
Chen Schor
resTORbio, Inc. - Co-Founder, President, CEO & Director

Good morning, everybody, and thank you for joining us today. My name is Chen Schor, and I'm President and CEO of resTORbio. And I'm very glad to welcome you to our KOL event today. Our mission at resTORbio is pretty ambitious. We're targeting the biology of aging to prevent or treat age-related diseases, that's a pretty ambitious vision. Our lead indication is to improve the function of the aging immune system and as the readout of improving the function of the aging immune system, we look to reduce the incidence of respiratory tract infection.

Today, we're going to focus on our second indication, which is improving the function of the neurologic system and our focus will be on Parkinson's disease. I'm going to hand it off to 2 leaders in their respective fields: TORC1 and aging, Dr. Matt Kaeberlein; and neurology, Dr. Roy Alcalay. And just before we get started, I'd like to quickly introduce Matt and Roy.

Matt is recognized globally for his research on the basic biology of aging. He is the President of the American

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot